NCT02838797View on ClinicalTrials.gov

RQ-00000010 for Gastroparesis and Constipation in Parkinson's Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

August 20, 2019

Study Completion Date

August 20, 2019

Conditions
Parkinson's DiseaseGastroparesisConstipation
Interventions
DRUG

RQ-00000010

orally administered serotonin 4 receptor partial agonist

DRUG

Placebo

oral acetate buffer

Trial Locations (1)

23233

VCU NOW Center, Henrico

All Listed Sponsors
collaborator

Michael J. Fox Foundation for Parkinson's Research

OTHER

collaborator

RaQualia Pharma Inc.

INDUSTRY

lead

Virginia Commonwealth University

OTHER

NCT02838797 - RQ-00000010 for Gastroparesis and Constipation in Parkinson's Disease | Biotech Hunter | Biotech Hunter